Either Ring1B or EZH2 knock down independently inhibited tumor growth of pancreatic cancer cells, and simultaneous silencing of Ring1B and EZH2 increased the inhibition ability (Figure 5E, F). This evidence concerns the gene EZH2 and familial pancreatic carcinoma.